IDUA and Scheie syndrome: Vera et al. have recently developed liposomes loaded with two plasmids encoding the CRISPR/Cas9 system and the alpha-L-iduronidase (IDUA) gene targeting the ROSA26 locus for mucopolysaccharidosis type I (MPS I) management [55].